Anti-KSV CyclinD [94B] Product
Blood cancer Skin cancer
Blood cancer Skin cancer
[…] (ER+) and human epidermal growth factor receptor positive (HER2+) tumours. Sample collected in 2016 from skin metastasis of Caucasian female, age 41 at time of collection with a primary diagnosis […]
[…] (ER+) and human epidermal growth factor receptor positive (HER2+) tumours. Sample collected in 2014 from skin metastasis of Caucasian female, age 54 at time of collection with a primary diagnosis […]
[…] inflammatory breast cancer (2007). Patient had no history of smoking, and experienced clinical metastasis to skin and lung. Patient had undergone radiation therapy of chest wall, supraclavicular nodes, and axilla […]
[…] rare disorder characterised by fibrous dysplasia of the bone, various endocrinopathies and hyperpigmented patches of skin. These murine melanocytes are hyperpigmented compared to littermate control lines. These melanocytes are a […]
[…] rare disorder characterised by fibrous dysplasia of the bone, various endocrinopathies and hyperpigmented patches of skin. These murine melanocytes are hyperpigmented compared to littermate control lines. These melanocytes are a […]
[…] rare disorder characterised by fibrous dysplasia of the bone, various endocrinopathies and hyperpigmented patches of skin. These murine melanocytes are hyperpigmented compared to littermate control lines. These melanocytes are a […]
[…] in the regulation of ultraviolet-induced gene expression. This line may be useful for the study of the tanning response upon ultraviolet irradiation which has implications for the development of skin cancers.
[…] expressed in various tissues and cell lineages, such as immune cells, adrenal glands, placenta, kidneys, skin and breast tissue, inner ear, hair follicles, and nervous system. GATA3 is responsible for […]
[…] cells or tissues, but not in platelets, hepatocytes, cardiac muscle, renal tubular epithelium, testis and skin portions. CD44 is a signalling platform that integrates cellular microenvironmental signals with growth factor […]
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.